Immune checkpoint inhibitors in neoadjuvant therapy of non-small cell lung cancer: a systematic review and meta-analysis

BACKGROUND: Our objective was to explore the safety and feasibility of immune checkpoint inhibitors (ICIs) in the neoadjuvant treatment of non-small cell lung cancer (NSCLC). METHODS: Embase, PubMed and Web of Science were systematically searched from 1(st) January 2018 to 1(st) August 2021 for stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Ge, Sa, Huang, Chenjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902100/
https://www.ncbi.nlm.nih.gov/pubmed/35280480
http://dx.doi.org/10.21037/jtd-21-1664

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902100/
https://www.ncbi.nlm.nih.gov/pubmed/35280480
http://dx.doi.org/10.21037/jtd-21-1664

Ejemplares similares